Taiwan FDA registration da71a9ce5cd82bbf4c9448586e5d00c6

"Parkstone" Baimetrix drug releases coronary stent system

TW: “柏盛”拜美翠弗雷絲藥物釋放冠狀動脈支架系統
Taiwan flagTaiwan·Risk Class 3·BIOSENSORS EUROPE SA;; BIOSENSORS INTERVENTIONAL TECHNOLOGIES PTE LTD.·Registered Dec 12, 2011 – Dec 12, 2021Cancelled
Registration details
Analysis ID
da71a9ce5cd82bbf4c9448586e5d00c6
Customs Code
DHA00602310807
Company information
Manufacturer Country
Switzerland;;Singapore
Product details
Intended Use
For details, it is Chinese approved copy of the imitation order
Product Type (Level 1)
E Cardiovascular Medicine Science
Import Information
import
Dates and status
Registration Date
Dec 12, 2011
Expiry Date
Dec 12, 2021
Cancellation Date
Oct 12, 2023
Cancellation information
Status
Logged out
Reason
未展延而逾期者
About this record

Access comprehensive regulatory information for "Parkstone" Baimetrix drug releases coronary stent system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number da71a9ce5cd82bbf4c9448586e5d00c6 and manufactured by BIOSENSORS EUROPE SA;; BIOSENSORS INTERVENTIONAL TECHNOLOGIES PTE LTD.. The authorized representative in Taiwan is IDS MEDICAL SYSTEMS (HONG KONG) COMPANY LIMITED, TAIWAN BRANCH (HONG KONG).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices